Lupin informs about annual report

20 Jul 2020 Evaluate

In compliance with Regulation 34(1) of the Listing Regulations, Lupin has informed that it has enclosed the Annual Report of the Company for the year ended March 31, 2020, along with the Notice convening the Thirty-Eighth Annual General Meeting at 4.00 pm (IST) on Wednesday, August 12, 2020. The Annual Report contains information prescribed by Regulations 34(2) and (3) of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×